secwatch.observer — SEC 8-K summary
======================================

Issuer:     Galera Therapeutics, Inc. (GRTX)
CIK:        0001563577
Form:       8-K
Filed at:   2023-02-16T23:59:59+00:00
Accession:  0001193125-23-041168
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Galera raises $30M in registered direct offering of stock and warrants
----------------------------------------------------------------------

- Offering of 14,320,000 shares at $2.095/share plus warrants to buy 14,320,000 shares at $1.97.
- Gross proceeds of $30M; net to fund avasopasem pre-commercialization, rucosopasem development, and working capital.
- Closing expected February 17, 2023; 90-day lock-up for officers and directors.
- Piper Sandler acted as sole placement agent; 6% placement fee on gross proceeds.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1563577/000119312523041168/0001193125-23-041168-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1563577/000119312523041168/d424770d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-041168

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer